Attending AIRR Community Meeting VII on reactome profiling

Alpha Atlas: Global Production Mapping of α-Emitting Radionuclides for Advanced Targeted Alpha Therapy

The National Cancer Strategy states that 90% of patients who receive radiotherapy should commence it within 15 days of being ready to treat. Last year only 6/10 patients began their radiotherapy treatment on time, compared to 8/10 people in 2018. Time and time again we have called on government to increase capacity and infrastructure to deliver the radiation therapy and care Irish patients deserve. More and more people are being diagnosed with cancer every year in Ireland. We need commitment from government to invest in long term solutions to meet future demand, including increasing radiation therapy university places. Review of radiation therapy staffing recommends 'urgent action' on vacancies (irishexaminer.com)

Jane A McKeating and Peter Revil from the McKeating Lab give us their insights from the HBV international meeting in Kobe, Japan. Read their blog here https://microb.io/3K9bJJ2 and their full article in #JGenVirol

This is our latest project with Prof. Samah Lotfy, presented in AACR conference

We're thrilled to attend the 2024 International HBV Meeting in Chicago next week! As part of our commitment to advancing research and treatment for viral and life-threatening illnesses, we're hosting a panel discussion on the critical role of patient perspectives in Hepatitis B research and treatment. Anne Kasmar, Parexel's Senior Vice President and Therapeutic Head of Infectious Disease, will moderate the discussion with a panel of experts representing diverse experiences in the Hepatitis B research community: - Patient leader- Wendy Lo, Patient Advocate - Foundation leader- Chari Cohen, President, Hepatitis B Foundation - Industry leader- Christine Livingston, Scientific Director, GlaxoSmithKline - Clinician- Roger Inouye, Senior Medical Director, Parexel - Academic researcher- Thomas Tu, Group Leader, Storr Liver Centre, The Westmead Institute Together, we'll explore how patient insights drive innovation, improve trial design, and shape research priorities in the fight against Hepatitis B. We'll discuss current challenges in Hepatitis B research and treatment and how increased patient engagement and collaboration can help overcome these obstacles. We look forward to a transformative discussion highlighting how patients will reshape the future of Hepatitis B research and treatment. Let's embrace a patient-guided approach across all phases of research to propel progress in treating and finding the cure for Hepatitis B! #HepatitisB #HepB #PatientPerspectives #PatientFirst

Check our recent publication. #USMIRC

Cervical cancer continues to pose a significant challenge in South Africa’s healthcare system, with thousands of women affected each year. Despite the availability of screening programs, access and follow-up care remain barriers to effective prevention and treatment. The CCPAC (Cervical Cancer Prevention and Control Project) is working diligently to strengthen the cervical cancer care cascade, ensuring that women receive comprehensive care from screening to treatment. By improving access to early detection, enhancing patient tracking, and empowering healthcare providers with the tools and resources they need, CCPAC is making a real difference in reducing the burden of cervical cancer in South Africa. Together, we can build a future where no woman dies from a preventable disease like cervical cancer. https://lnkd.in/g9VJYa3t

🎬 That's a wrap on day 3 of #ASCO24! 🔍 Catch up on the conference's breakthroughs and insights here:

During this session of the 2023 Joint HPVRT/NRTCC National Meeting, we learned new information relative to emerging, on-the-horizon topics, including the elimination of HPV cancers, self-sampling for cervical cancer screening and one-dose implications for HPV vaccination.